查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
楔压导管市场——增长、趋势、COVID-19 影响和预测 (2023-2028)
市场调查报告书
商品编码
1273527

楔压导管市场——增长、趋势、COVID-19 影响和预测 (2023-2028)

Wedge Pressure Catheter Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计在预测期内，楔压导管市场的复合年增长率为 6.5%。

全球 COVID-19 病例数的增加和封锁情况最初对市场产生了重大影响，因为治疗、诊断和手术等服务被暂停以防止 COVID-19 的传播。稻田。 COVID-19 对心血管的影响是惊人的和多方面的。 美国国家医学图书馆 2020 年 12 月发表的一项研究发现，COVID-19 患者的肺动脉楔压高于急性呼吸窘迫综合征 (ARDS) 患者，并且与肺顺应性呈负相关。 因此，在 COVID-19 中，由于凝血障碍和伴随的静脉和动脉血栓栓塞对循环系统的广泛影响，需要楔形压力导管。 此外，自 COVID-19 以来，全球限制已经放鬆，疾病筛查服务已经恢復，因此在当前情况下市场增长正在稳定。

被诊断患有心血管疾病和中风的患者数量不断增加是推动市场增长的主要因素。 根据世界中风组织（WSO）2022年公布的数据，约有1200万人（12224551人）经历过中风。 该组织表示，每年有超过 1220 万例新中风，在全球范围内，25 岁以上的人中有四分之一在其一生中会经历中风。 因此，全球患者负担的增加正在增加对外科手术的需求，预计这将在预测期内进一步推动楔压导管市场的增长。

此外，根据英国心臟基金会 2022 年 1 月发布的一项研究，英国约有 760 万心脏病患者。 英国平均每天有 460 例 CVD 死亡，或每三分钟一例。 心血管疾病负担的增加推动了对可降低心力衰竭相关死亡率的创新技术的需求，这在研究期间增加了对楔形压力导管的需求。

心脏病，包括冠心病、高血压和中风，是美国的头号死因。 此外，由于为开发治疗各种心脏病和中风管理的新技术而进行的研发活动不断增加，预计在预测期内将实现盈利增长。

但是，楔压导管的问题以及新兴市场缺乏训练有素的医务人员可能会减缓市场增长。

楔压导管市场趋势

从应用来看，肺动脉段预计将占据最大的市场份额

近年来，肺动脉部分的收入份额最大，预计在预测期内仍将如此。 这种优势源于心血管疾病的高患病率以及主要参与者针对不同条件推出的不同类型产品的可用性，导致需求增加。 此外，用于监测动脉压的楔形压力导管的迅速采用预计将增加製造商的需求并推动全球市场。

根据 Pulmonary Circulation 于 2022 年 1 月发表的一篇文章，肺动脉高压 (PAH) 的特征是血管重塑导致肺孔阻力增加。 患病率范围为每 100,000 人 0.4 至 1.4 人。 此外，根据 2021 年 8 月发布的 WHO Key Facts，全世界有 12.8 亿 30-79 岁的成年人患有高血压，其中大多数（三分之二）生活在低收入和中等收入国家。 非传染性疾病的全球目标之一是在 2010 年至 2030 年间将高血压患病率降低 33%。 肺动脉高压患病率的增加和老年人口的增加是推动肺动脉段市场增长的主要因素。

根据世界卫生组织的数据，到 2050 年，世界上 60 岁及以上的人口将比上一年翻一番，达到 22%。 肺动脉高压的症状包括呼吸急促（呼吸困难）、胸痛和昏厥，尤其是在运动期间。 由于老年人口越来越多，与肺动脉高压有关的并发症也越来越多。 所有这些因素都在推动这一细分市场的增长。

楔形压力导管市场-IMG1

北美在市场上占主导地位，预计在预测期内也会如此。

在整个预测期内，预计北美将主导整个楔压导管市场。 北美楔压导管市场增长的主要驱动因素是心血管疾病负担的增加、技术采用的增加、产品批准的增加、投资的增加以及政府的举措。

根据美国疾病预防控制中心的一份报告（2021 年更新的统计数据），美国人每 40 秒就有可能心脏病发作一次。 因此，患有心血管疾病的人的负担很高，对楔形压力导管的需求预计会增加。 因此，预计将推动该地区的市场。

此外，提高认识、高诊断率和政府支持措施预计将在预测期内进一步推动市场增长。 根据美国疾病控制与预防中心 2022 年 8 月发布的数据，百万心臟计划是一项旨在在五年内预防 100 万例心脏病发作和中风的国家计划。 它侧重于实施一小组以证据为基础的优先事项和目标，以改善每个人的心血管健康。 另一个例子是世卫组织的全球 HEARTS 倡议，该倡议促进 CVD 预防，包括加强烟草控制、减少膳食盐摄入量、增加身体活动、消除工业生产饮食中的反式脂肪以及管理 CVD 风险。支持各国加强行动

因此，上述因素预计将在预测期内推动该地区的市场增长。

楔形压力导管市场-IMG2

楔形压力导管行业概况

楔压导管市场竞争适中，由几家大型企业组成。 一些公司正在扩大其市场地位，而另一些公司则采取各种战略，如收购、兼併和推出新产品，以保持其市场份额。 Alpha Medical Instruments LLC、Advanced Lifesciences Pvt. Ltd.、Teleflex Incorporated、DeRoyal Industries 和 ICU Medical Inc. 等公司占据了重要的市场份额。

其他福利：

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 调查假设和市场定义
  • 本次调查的范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 增加心脏病和中风患者的负担
    • 启动研发活动，开发心脏病和中风管理新技术
  • 市场製约因素
    • 与楔压导管相关的并发症
    • 新兴经济体缺乏熟练的医疗保健专业人员
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模）

  • 按材料
    • 聚氨酯
    • 尼龙
    • 其他材料
  • 通过使用
    • 肺动脉
    • 中央静脉
    • 心室
    • 其他用途
  • 最终用户
    • 医院
    • 专科门诊
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东和非洲地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Alpha Medical Instruments LLC
    • Advanced Lifesciences Pvt Ltd.
    • Teleflex Incorporated
    • DeRoyal Industries
    • ICU Medical Inc
    • Nolato AB
    • Edwards Lifesciences
    • B. Braun Melsungen AG
    • Merit Medical Systems Inc.

第7章 市场机会与将来动向

简介目录
Product Code: 67671

The wedge pressure catheter market is expected to register a CAGR of 6.5% over the forecast period.

The rising COVID-19 cases across the world and the lockdown situation had a significant impact on the market, initially due to on-hold services such as treatment, diagnostic, and surgical services to prevent the spread of COVID-19. The impact of COVID-19 on the cardiovascular system was prominent and multifaceted. As per the study published in December 2020 by the National Library of Medicine, pulmonary artery wedge pressure was higher in COVID-19 patients than in acute respiratory distress syndrome (ARDS) patients and inversely related to lung compliance. Therefore, there was a need for wedge pressure catheters during COVID-19, as they had wide-ranging effects on the cardiovascular system due to coagulopathy and resultant venous and arterial thromboembolism. Furthermore, market growth is stabilizing in the current scenario following COVID-19, as global restrictions were eased and disease screening services were resumed.

The increasing number of patients diagnosed with cardiovascular diseases and stroke is a major factor driving market growth.According to data published by the World Stroke Organization (WSO) in 2022, about 12 million (12,224,551) people experienced a stroke. The organization stated that there are more than 12.2 million new strokes each year, and globally, one in four people after age 25 experiences a stroke in their lifetime. Hence, the increasing burden of patients globally is expected to drive the demand for surgical procedures, which is further expected to drive the wedge pressure catheter market growth over the forecast period.

Moreover, according to a study published by the British Heart Foundation in January 2022, there were approximately 7.6 million people with heart disease in the United Kingdom. An average of 460 deaths per day, or one death every three minutes, happen in the United Kingdom due to CVDs. Due to the rising burden of cardiovascular diseases, there is an increasing demand for innovative technologies that can decrease the mortality rates associated with heart failure, thereby increasing the demand for wedge pressure catheters during the study period.

Heart diseases like coronary heart disease, hypertension, and stroke are ranked as the highest cause of death in the United States. Furthermore, an increase in research and development activities to develop novel technologies to treat various cardiac disorders and stroke management is expected to see profitable growth during the forecast period.

But problems with the wedge pressure catheter and a lack of trained medical professionals in emerging markets are likely to slow the market's growth.

Wedge Pressure Catheter Market Trends

Pulmonary Artery Segment by Application is Expected to Hold the Largest Market Share

The pulmonary artery segment accounted for the largest revenue share in recent years and is expected to do so over the forecast period. This dominance is owing to the increased demand due to the high incidence rate of cardiovascular diseases and the availability of various types of products launched by the key players that are suitable for various disease conditions. Furthermore, the rapid increase in the adoption of wedge pressure catheters for monitoring arterial pressure is also expected to increase the demand for manufacturers, which will drive the global market.

As per an article published in January 2022 by Pulmonary Circulation, pulmonary arterial hypertension (PAH) is characterized by increased resistance in the pulmonary arterioles because of remodeled blood vessels. The prevalence ranged from 0.4 to 1.4 per 100,000 people. Moreover, according to WHO key facts published in August 2021, an estimated 1.28 billion adults worldwide aged 30-79 years have hypertension, with most (two-thirds) living in low- and middle-income countries. One of the global targets for non-communicable diseases is to reduce the prevalence of hypertension by 33% between 2010 and 2030. The increasing prevalence of pulmonary arterial hypertension and the growing geriatric population are the main factors that are boosting the growth of the pulmonary artery segment's market.

According to the WHO, by 2050, the world's population over 60 will nearly double to 22% from the previous year. The symptoms of pulmonary arterial hypertension include shortness of breath (dyspnea), especially during exercise, chest pain, and fainting. The increase in the number of geriatrics leads to consequences that, in several cases, include complications related to pulmonary arterial hypertension. All these factors boost the growth of the segment.

Wedge Pressure Catheter Market - IMG1

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the overall wedge pressure catheters market throughout the forecast period. The primary driving factors for the growth of the North American wedge pressure catheter market are the growing burden of cardiovascular diseases, the rising adoption of technologies, increasing product approvals, increasing investments, and initiatives taken by the government.

According to a report by the United States CDC (statistics updated in 2021), every 40 seconds, an American may have a heart attack. Thus, there is a high burden of people suffering from cardiovascular diseases, which are expected to increase the demand for wedge pressure catheters. This is expected to drive the market in the region.

Moreover, increased awareness, a high diagnosis rate, and supportive government initiatives are further expected to boost the growth of the market over the forecast period. According to Centers for Disease Control and Prevention data published in August 2022, Million Hearts is a national initiative to prevent 1 million heart attacks and strokes within 5 years. It focuses on implementing a small set of evidence-based priorities and targets that can improve cardiovascular health for all. Another instance is the WHO global HEARTS Initiative, which supports countries strengthening actions to prevent CVD, such as enhanced tobacco control, dietary salt reduction, increasing physical activity, the elimination of industrially produced dietary trans-fats, and the management of CVD risks.

Therefore, the above-mentioned factors are expected to drive market growth in the region during the forecast period.

Wedge Pressure Catheter Market - IMG2

Wedge Pressure Catheter Industry Overview

The Wedge Pressure Catheter Market is moderately competitive and consists of several major players. Some of the companies are expanding their market position, while others are adopting various strategies such as acquisitions, mergers, and introducing new products to maintain their market share. Companies like Alpha Medical Instruments LLC, Advanced Lifesciences Pvt. Ltd., Teleflex Incorporated, DeRoyal Industries, and ICU Medical Inc., among others, hold a substantial market share.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Cardiac Diseases and Stroke Cases
    • 4.2.2 Growing R&D Activities to Develop Novel Technologies in Cardiac Stroke Management
  • 4.3 Market Restraints
    • 4.3.1 Complications Associated with the Wedge Pressure Catheters
    • 4.3.2 Lack of Skilled Healthcare Professionals in Emerging Markets
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Material
    • 5.1.1 Polyurethane
    • 5.1.2 Nylon
    • 5.1.3 Other Materials
  • 5.2 By Application
    • 5.2.1 Pulmonary Artery
    • 5.2.2 Central Venous
    • 5.2.3 Ventricular
    • 5.2.4 Other Applications
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Specialty Clinics
    • 5.3.3 Other End-Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United states
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alpha Medical Instruments LLC
    • 6.1.2 Advanced Lifesciences Pvt Ltd.
    • 6.1.3 Teleflex Incorporated
    • 6.1.4 DeRoyal Industries
    • 6.1.5 ICU Medical Inc
    • 6.1.6 Nolato AB
    • 6.1.7 Edwards Lifesciences
    • 6.1.8 B. Braun Melsungen AG
    • 6.1.9 Merit Medical Systems Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS